Dyne Therapeutics: Updates on DELIVER Trial

Dyne Therapeutics Announces New Clinical Data from DELIVER Trial of DYNE-251 in DMD Demonstrating Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints. Tune in to hear from Dyne Therapeutics on updates in their DELIVER trial for Duchenne muscular dystrophy.

Palliative Care Webinar

Jett’s Community Webinar Series featuring a presentation from Dr. Ashley Nichols of Palliative & Supportive Care teams at Children’s of Alabama and UAB.